Enliven Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.8M | 45k | 39.20 |
| 2024-12-31 | $769k | 34k | 22.50 |
| 2024-09-30 | $1.2M | 49k | 25.54 |
| 2024-06-30 | $800k | 34k | 23.37 |
| 2024-03-31 | $294k | 17k | 17.59 |
| 2023-12-31 | $425k | 31k | 13.84 |
| 2023-09-30 | $316k | 23k | 13.66 |
| 2023-06-30 | $348k | 17k | 20.41 |
| 2023-03-31 | $143k | 6.5k | 21.90 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation